Spanish tools of cognitive and behavior assessment of alzheimer´s disease in severe state
e202009099
Keywords:
Validation research, Severe dementia, Alzheimer’s disease, Neuropsychological assessmentAbstract
Background: There are different scales in Spanish for cognitive and behavioral assessment of patients with severe dementia. The objective of this study was to select those scales that are more accessible, useful and with better psychometric properties, both for clinical practice and for research.
Methods: Literature review, by experts in the field, of scales of cognitive and behavioral assessment in dementia in the main scientific databases. Published in Spanish or English, excluding those not validated in Spanish.
Results: 11 bibliographical references were selected. Cognitive scales: Severe Impairment Battery was the one with the most cognitive areas, its abbreviated version (SIB-s) had the best internal consistency (α=0.96), Baylor Profound Mental Status Examination had very good psychometric properties with 0.99 reliability and excellent concurrent validity with Mini-Mental State Examination (r=-0.91). Severe Cognitive Impairment Profile was the only one that allowed establishing subgroups of cognitive impairment. Behavioral scales: Neuropsychiatric Inventory was the gold standard in dementias, but there was only one specific scale for severe Alzheimer’s disease, the Baylor Profound Mental Status Examination behavioral subscale.
Conclusions: In Spanish severe dementia, Severe Cognitive Impairment Profile and the Neuropsychiatric Inventory are the gold standard tool for cognitive assessment for research studies, and the Baylor Profound Mental Status Examination is the most useful for daily clinical practice.
Downloads
References
Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol 2016; 15:455-532.
De Pedro-Cuesta J, Virués-Ortega J, Vega S. Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008. BMC Neurol 2009; 9, 55.
Tom SE, Hubbard RA, Crane PK, Haneuse SJ, Bowen J, McCormick WC et al. Characterization of dementia and Alzheimer’s disease in an older population: updated incidence and life expectancy with and without dementia. Am J Public Health 2015; 105: 408-13.
Boller F, Verny M, Hugonot-Diener L, Saxton J. Clinical features and assessment of severe dementia: a review. Eur J Neurol 2002; 9: 125-36.
Mattis S. DRS: Dementia Rating Scale professional manual. Odessa, FL: Psychological Assessment Resources. 1988.
Doody RS, Strehlow SL, Massman PJ, Feher EP, Clark C, Roy JR. Baylor profound mental status examination: A brief staging measure for profoundly demented Alzheimer disease patients. Alzheimer Dis Assoc Disord 1999; 13: 53-59.
García FJ, Manubens JM. Enfermedad de Alzheimer evolucionada. Concepto y epidemiología. Med Clin Monogr (Barc) 2004; 5: 3-8.
Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988; 24: 653-9.
Newhouse P, Lasek J. Assessment and diagnosis of severe dementia. En: Burns A, Winblad B (eds.), Severe Dementia (pp. 3-20). Sussex, London: John Wiley & Sons Ltd. 2006.
Saxton J, Boller F. Cognitive functions in severe dementia. En Burns A, Winblad B (eds.), Severe Dementia (pp. 43-50). Sussex, London: John Wiley & Sons Ltd. 2006.
Hui JS, Wilson RS, Bennett DA, Bienias JL, Gilley DW, Evans DA. Rate of cognitive decline and mortality in Alzheimer´s disease. Neurology 2003; 61: 1356-61.
Grupo de trabajo de la Guía de Práctica Clínica sobre la Atención Integral a las Personas con Enfermedad de Alzheimer y otras Demencias. Guía de Práctica Clínica sobre la Atención Integral a las Personas con Enfermedad de Alzheimer y otras Demencias [versión resumida]. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad, Política Social e Igualdad. Agència d´Informació, Avaluació i Qualitat en Salut (AIAQS) de Cataluña; 2010. Guías de Práctica Clínica en el SNS: AIAQS N.º 2009/07.
Folstein MF, Folstein SE, McHugh PR. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
Lobo A, Ezquerra J, Gómez F, Sala JM, Seva A. El «Mini-Examen Cognoscitivo»: un test sencillo, práctico, para detectar alteraciones intelectivas en pacientes médicos. Actas Luso-Esp Neurol Psiquiatr 1979; 3: 189-202.
Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975; 23: 433-41.
Rami L, Molinuelo JL, Sánchez-Valle R, Bosch B, Villar A. Screening for amnestic mild cognitive impairment and early Alzheimer’s disease with M@T (Memory Alteration Test) in the primary care population. Int J Geriatr Psychiatry 2007; 22: 294-304.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-9.
Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811.
Erzigkeit H. The SKT: a short cognitive performance test as an instrument for the assessment of clinical efficacy of cognition enhances. En Bergener M, Reisberg B (eds.), Diagnosis and treatment of senile dementia (pp. 164-74). Berlín: Springer Verlag. 1989.
Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. The short test of mental status. Correlations with standardized psychometric testing. Arch Neurol 1991; 48: 725-8.
Solomon PR, Hirschoff A, Kelly B, Relin M, Brush M, DeVeaux RD et al. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer’s disease. Arch Neurol 1998; 55: 349-55.
Belle SH, Mendelsohn AB, Seaberg EC, Ratcliff G. A brief cognitive screening battery for dementia in the community. Neuroepidemiology 2000; 19: 43-50.
Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 2000; 15: 1021-7.
Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 2002; 50: 530-4.
De Yébenes MJ, Otero A, Zunzunegui MV, Rodríguez-Laso A, Sánchez-Sánchez F, Del Ser T. Validation of a short cognitive tool for the screening of dementia in elderly people with low educational level. Int J Geriatr Psychiatry 2003; 18: 925-36.
Carnero-Pardo C, Montoro-Ríos M. Evaluación preliminar de un nuevo test de cribado de demencia (EUROTEST). Rev Neurol 2004; 38: 201-9.
Carnero-Pardo C, Montoro Ríos M. El Test de las Fotos. Rev Neurol 2004; 39: 801-6.
Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM et al. Screening for dementia with the memory impairment screen. Neurology 1999; 52: 231-8.
Cacho J, García-García R, Arcaya J, Vicente JL, Lantada N. Una propuesta de aplicación y puntuación del Test del Reloj en la enfermedad de Alzheimer. Rev Neurol 1999; 28: 648-55.
Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1972; 1: 233-8.
Mendiondo MS, Ashford JW, Kryscio RJ, Schnitt FA. Designing a Brief Alzheimer Screen (BAS). J Alzheimers Dis 2003; 5: 391-8.
Manzano JM, Llorca G, Ledesma A, López-Ibor JJ. Spanish adaptation of the Alzheimer’s disease assessment scale (ADAS). Actas Luso Esp Neurol Psiquiatr Cienc Afines 1994; 22: 64-70.
López-Pousa S, Llinás J, Amiel J, Vdal C, Vilalta J. CAMDEX: una nueva entrevista psicogeriátrica. Actas Luso-españolas Neurol. Psiquiatr 1990; 18: 290-5.
Peña-Casanova J, Guardia J, Bertran-Serra I, Manero RM, Jarne A. Versión abreviada del test Barcelona (I): subtests y perfiles normales. Neurología 1997; 12: 99-111.
Ostrosky-Solís F, Ardila A, Rosselli M. NEUROPSI: a brief neuropsychological test battery in Spanish with norms by age and educational level. J Int Neuropsychol Soc 1999; 5: 413-33.
Sánchez R, Ibáñez MA, Pinzón A. Factor analysis and validation of a Spanish version of the Brief Psychiatric Rating Scale in Colombia. Biomedica. 2005; 25(1): 120-8.
Vilalta-Franch J, Lozano-Gallego M, Hernández-Ferrándiz M, Llinás-Regla J, López-Pousa S, López OL. The Neuropsychiatric Inventory Psychometric properties of its adaptation into Spanish. Rev Neurol 1999; 29: 15-19.
Boada M, Cejudo JC, Tàrraga L, López OL, Kaufer D, Tanaka H. Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the Neuropsychiatric Inventory (NPI). Neurologia. 2002; 17(6): 317-23.
Boada M, Tárraga L, Modinos G, Diego S, Reisberg B. Behavioral pathology in Alzheimer’s Disease Rating Scale (BEHAVE-AD): Spanish validation. Neurologia 2006; 21: 19-25.
Salmerón S, Huedo I, López-Utiel M, Soler-Moratalla I, Flores-Ruano T, Fernández-Sánchez M, Noguerón A et al. Validation of the Spanish Version of the Baylor Profound Mental Status Examination. J Alzheimers Dis 2015; 49: 73-8.
Cruz-Orduña I, Agüera-Ortiz LF, Montorio-Cerrato I, LeónSalas B, Valle de Juan MC, Martínez-Martín P. Fiabilidad y validez de la batería de evaluación del deterioro grave, versión abreviada (SIB-s), en pacientes con demencia en España. Rev Neurol 2015; 60: 1-9.
Salmerón S, Lozoya S, Plaza L, Soler-Moratalla I, Solís J, Abizanda P. Validation Prognostic of the Baylor Profound Mental Status Examination. Dement Geriatr Cogn Disord. 2019;48(1-2):113-122.
Buiza C, Navarro A, Díaz-Orueta U, González MF, Álaba J, Arriola E et al. Evaluación breve del estado cognitivo de la demencia en estadios avanzados: resultados preliminares de la validación española del Severe Mini-Mental State Examination. Rev Esp Geriatr Gerontol 2011; 46: 131-8.
Buiza C, Montorio-Cerrato I, Yanguas J. The validity and reliability of the Spanish version of the Severe Cognitive Impairment Profile (SCIP) for the cognitive assessment of persons with advanced stages of Alzheimer’s disease. Rev Neurol 2015; 61: 349-56.
Cejudo JC, Torrealba E, García P, Auer S, Castrillo S, Peña-Casanova J. Modified Ordinal Scales of Psychological Development (M-OSPD). A study of cognitive impairment. Psicogeriatría 2011; 3: 87-92.
Llinàs-Regla J, Lozano M, López OL, Gudayol M, López-Pousa S, Vilalta J et al. Validación de la adaptación española de la Severe Impairment Battery (SIB). Neurologia 1995; 10: 14-8.
Salmerón S [Internet]. Basel: Validación de la escala Baylor Profoud Mental Status Examination al español [cited 2016 Jun 1]. Available from: https://ruidera.uclm.es/xmlui/bitstream/handle/10578/10905/TESIS%20Salmer%C3%B3n%20R%C3%ADos.pdf?sequence=1&isAllowed=y. Accessed July 1, 2019.
Weschler D, Pereña J. WMS-III: escala de memoria de Wechsler-III Madrid: TEA. 2004.
Peña-Casanova J, Quiñones-Ubeda S, Quintana-Aparicio M, Aguilar M, Badenes D, Molinuevo JL et al. Spanish Multicenter Normative Studies (NEURONORMA Project): norms for verbal span, visuospatial span, letter and number sequencing, trail making test, and symbol digit modalities test. Arch Clin Neuropsychol 2009; 24: 321-41.
Nagata Y, Uematsu M, Takebayashi T, Hanada K, Inokawa M et al. Development of the Cognitive Test for Severe Dementia. Dement Geriatr Cogn Disord. 2015; 40(1-2): 94-106.
Albert MA, Cohen C. The Test for the Severe Impairment: An instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc 1992; 40: 449-53.
Ward T, Dawe B, Procter A, Murphy E, Weinman J. Assessment in severe dementia: the Guy,s Advanced Dementia Schedule. Age Ageing 1993; 22: 183-9.
Devanand DP, Miller L, Richards M, Marder K, Bell K, Mayeux R et al. The Columbia University Scale for Psychopathology in Alzheimer’s disease. Arch Neurol. 1992; 49: 371-6.
Peña-Casanova J, Aguilar M, Santacruz P, Bertran-Serra I, Hernández G, Sol JM et al. Adaptation and normalization of the Alzheimer’s disease Assessment Scale for Spain (NORMACODEM) (II). Neurologia 1997; 12: 69-77.
Na HR, Lee SH, Lee JS, Doody RS, Kim SY. Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer’s disease. Dement Geriatr Cogn Disord 2009; 27: 69-75.
Piaget J. The origins of intelligence in children. London: Routledge & Kegan Paul; 1952.
Reisberg B, Ferris DH, Franssen E. Functional degenerative stages in dementia of the Alzheimer´s type appear to reverse normal human development. En Shagass C, et al (eds.), Biological psychiatry (pp. 1319-21). NY: Elsevier Science. 1986.
Kørner A, Brogaard A, Wissum I, Petersen U. The Danish version of the Baylor Profound Mental State Examination. Nord J Psychiatry 2012; 66: 198-202.
Saxton J, Kastango KB, Hugonot-Diener L, Boller F, Verny M, Sarles CE et al. Development of a short form of the Severe Impairment Battery. Am J Geriatr Psychiatry 2005; 13: 999-1005.
Hugonot-Diener L, Verny M, Devouche E, Saxton J, Mecocci P, Boller F. Abridged version of the severe impairment battery (SIB). Psychol Neuropsychiatr Vieil 2003; 1: 273-83.
Ahn IS, Kim JH, Saxton J, Kim DK. Reliability and validity of a short form of the Severe Impairment Battery in Korean Alzheimer’s disease patients. Int J Geriatr Psychiatry 2007; 22: 682-7.
De Jonghe JF, Wetzels RB, Mulders A, Zuidema SU, Koopmans RT. Validity of the Severe Impairment Battery Short Version. J Neurol Neurosurg Psychiatry 2009; 80: 954-9.
Auer S, Reisberg B. Manual for the uses of Modified Ordinal Scales of Psychological Development (M-OSPD) in patients with severe dementia. New York: Ontogeny; 1995.
Auer SR, Sclan SG, Yaffe RA, Reisberg B. The neglected half of Alzheimer’s disease: cognitive and functional concomitants of severe dementia. J Am Geriatr Soc 1994; 42: 1266-72.
Feldman HH, Qady N. Addresing severe Alzheimer´s disease: A clinical approach. The Canadian review of Alzheimer´s disease and other dementias 2006; 8: 4-9.
Pekkala S, Albert ML, Spiro A, Erkinjuntti T. Perseveration in Alzheimer´s Disease. Dementia and Geriatic Cognitive Disorders 2008; 25: 109-14.
Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol 1988; 24: 97-9.
Eckert SL, Diamond PM, Miller AL, Velligan DI, Funderburg LG, True JE. A comparison of instrument sensitivity to negative symptom change. Psychiatric Research 1996; 63: 67-75.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Sergio Salmerón Ríos, Silvia Lozoya Moreno, Isabel Soler Moratalla, Raúl Salmerón Ríos, Laura Ramírez Relinque, Pedro Abizanda Soler
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
![¿Cómo evaluar para la RESP? [PARA REVISORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-revisores-0eaa113abcbc4fc554c7c6c7840ca4c6.jpg)
![¿Cómo recibir avisos sobre nuevos artículos de la RESP? [PARA LECTORES]](https://ojs.sanidad.gob.es/public/site/images/rmartinb/pastilla-lectores-aa689338e95aab07df45b4b0d583188f.jpg)
